Historical Stock Price
SYBX historical stock prices picture
Synlogic (SYBX) has the following price history information. Looking back at SYBX historical stock prices for the last five trading days, on April 15, 2024, SYBX opened at $1.73, traded as high as $1.83 and as low as $1.71, and closed at $1.80. Trading volume was a total of 38.10K shares. On April 16, 2024, SYBX opened at $1.77, traded as high as $1.82 and as low as $1.71, and closed at $1.80. Trading volume was a total of 27.20K shares. On April 17, 2024, SYBX opened at $1.78, traded as high as $1.82 and as low as $1.73, and closed at $1.77. Trading volume was a total of 40.00K shares. On April 18, 2024, SYBX opened at $1.78, traded as high as $1.87 and as low as $1.72, and closed at $1.83. Trading volume was a total of 70.30K shares. On April 19, 2024, SYBX opened at $1.84, traded as high as $1.89 and as low as $1.78, and closed at $1.87. Trading volume was a total of 54.40K shares.

SYBX Historical Stock Prices By Date:

SYBX historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Synlogic shares, starting with a $10,000 purchase of SYBX, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/01/2015
End date: 04/19/2024
Start price/share: $740.25
End price/share: $1.87
Dividends collected/share: $0.00
Total return: -99.75%
Average Annual Total Return: -50.29%
Starting investment: $10,000.00
Ending investment: $25.28
Years: 8.56
Date Open High Low Close Volume
04/15/2024 $1.73 $1.83 $1.71 $1.80 38.10K
04/16/2024 $1.77 $1.82 $1.71 $1.80 27.20K
04/17/2024 $1.78 $1.82 $1.73 $1.77 40.00K
04/18/2024 $1.78 $1.87 $1.72 $1.83 70.30K
04/19/2024 $1.84 $1.89 $1.78 $1.87 54.40K
Synlogic is a clinical-stage biopharmaceutical company applying synthetic biology to the discovery and development of synthetic biotic. Co.'s pipeline includes: SYNB1934, which is an orally administered, non-systemically absorbed drug candidate based on a genetically engineered form of the probiotic E. coli Nissle; SYNB1353, which is a drug candidate designed to consume methionine, in the gastrointestinal (GI) tract thereby lowering homocysteine levels in patients with homocystinuria; SYNB8802, which is being developed for the treatment of enteric hyperoxaluria, a chronic, progressive disease; and SYNB2081, which is a synthetic biotic designed to consume uric acid in the GI tract.
Date Close
04/15/2024$1.80
04/16/2024$1.80
04/17/2024$1.77
04/18/2024$1.83
04/19/2024$1.87
SYBX is categorized under the Healthcare sector; below are some other companies in the same sector:

SYK Historical Stock Prices
SYN Historical Stock Prices
SYRS Historical Stock Prices
TARO Historical Stock Prices
TBIO Historical Stock Prices
TBRA Historical Stock Prices
TCMD Historical Stock Prices
TCON Historical Stock Prices
TDOC Historical Stock Prices
TEAR Historical Stock Prices

Also explore: SYBX shares outstanding history

Email EnvelopeFree SYBX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


SYBX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.